Chemed Corporation Declares Quarterly Dividend of $0.60 (NYSE:CHE)

Chemed Corporation (NYSE:CHEGet Free Report) declared a quarterly dividend on Friday, February 13th. Shareholders of record on Monday, February 23rd will be given a dividend of 0.60 per share on Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, February 23rd.

Chemed has increased its dividend by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 16 consecutive years. Chemed has a payout ratio of 8.7% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Chemed to earn $23.30 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 10.3%.

Chemed Stock Performance

Shares of NYSE CHE traded up $3.24 during midday trading on Friday, reaching $475.35. The stock had a trading volume of 124,633 shares, compared to its average volume of 168,831. The company has a market capitalization of $6.73 billion, a price-to-earnings ratio of 25.14, a price-to-earnings-growth ratio of 2.30 and a beta of 0.44. Chemed has a 12-month low of $408.42 and a 12-month high of $623.60. The stock has a 50-day moving average of $444.77 and a 200-day moving average of $443.47.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the sale, the chief executive officer directly owned 94,197 shares in the company, valued at $41,215,897.35. The trade was a 2.08% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 3.29% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in CHE. Commonwealth Equity Services LLC raised its position in Chemed by 3.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock valued at $314,000 after purchasing an additional 22 shares during the period. WCM Investment Management LLC raised its holdings in Chemed by 3.8% during the 3rd quarter. WCM Investment Management LLC now owns 661 shares of the company’s stock valued at $299,000 after buying an additional 24 shares during the period. Eukles Asset Management lifted its position in Chemed by 0.4% in the third quarter. Eukles Asset Management now owns 6,031 shares of the company’s stock worth $2,700,000 after buying an additional 24 shares during the last quarter. Cim LLC boosted its stake in Chemed by 1.1% during the third quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after buying an additional 24 shares during the period. Finally, Atria Investments Inc increased its position in Chemed by 0.6% during the second quarter. Atria Investments Inc now owns 4,259 shares of the company’s stock valued at $2,074,000 after acquiring an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

About Chemed

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Featured Stories

Dividend History for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.